Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects

A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as wel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2017-10, Vol.8 (49), p.84889-84901
Hauptverfasser: Manukyan, Gayane, Papajik, Tomas, Gajdos, Petr, Mikulkova, Zuzana, Urbanova, Renata, Gabcova, Gabriela, Kudelka, Milos, Turcsányi, Peter, Ryznerova, Pavlina, Prochazka, Vit, Kriegova, Eva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 84901
container_issue 49
container_start_page 84889
container_title Oncotarget
container_volume 8
creator Manukyan, Gayane
Papajik, Tomas
Gajdos, Petr
Mikulkova, Zuzana
Urbanova, Renata
Gabcova, Gabriela
Kudelka, Milos
Turcsányi, Peter
Ryznerova, Pavlina
Prochazka, Vit
Kriegova, Eva
description A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy controls. Neutrophils from CLL produced more reactive oxygen species (ROS) compared to controls in both resting and activated conditions. Lipopolysaccharide-induced production of IL-1β and TNF-a as well as reduced TLR2 expression in neutrophils from CLL than in neutrophils from controls suggesting their tolerant state. Finally, phenotypic alterations of neutrophils, particularly elevation of CD64 and CD54 markers, correlated with disease activity and treatment, and low percentage of neutrophils. Taken together, the alterations in percentage and functional characteristics of neutrophils reflect the clinical course of CLL. Our data provide first evidence that neutrophils in CLL are permanently primed and have functional defects.
doi_str_mv 10.18632/oncotarget.20031
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5689581</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1966983935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-2f638a819f6c7da810f17bb95090963fce654e48e229910e301b4eaf6dd15a0f3</originalsourceid><addsrcrecordid>eNpVUctO3TAQtVARIMoHsKm87OaCHce-8aZShVpAQrApa2uuMyamiZ3azpXu3-PyKp3NHM3jzOMQcsrZGe-UaM5jsLFAesBy1jAm-B454rrVq0ZK8ekDPiQnOT-yarJdd40-IIeN5lIpzY8I3OJSUpwHP2bqA7VDisFbOu6meYh2V_5iXH7j5IFCQjpjmiBgKOOOgi1-CwV7CqGnA2yRuiXUYAww0h4d2pI_k30HY8aTV39M7n_--HVxtbq5u7y--H6zskKqsmqcEh10XDtl130FzPH1ZqMl00wr4Swq2WLbYdNozRkKxjctglN9zyUwJ47JtxfeedlM2Nu6YoLRzMlPkHYmgjf_Z4IfzEPcGqk6LTteCb6-EqT4Z8FczOSzxXGs58YlG67ryzqhhayl_KXUpphzQvc-hjPzrI75p455Vqf2fPm433vHmxbiCeEXkSI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1966983935</pqid></control><display><type>article</type><title>Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Manukyan, Gayane ; Papajik, Tomas ; Gajdos, Petr ; Mikulkova, Zuzana ; Urbanova, Renata ; Gabcova, Gabriela ; Kudelka, Milos ; Turcsányi, Peter ; Ryznerova, Pavlina ; Prochazka, Vit ; Kriegova, Eva</creator><creatorcontrib>Manukyan, Gayane ; Papajik, Tomas ; Gajdos, Petr ; Mikulkova, Zuzana ; Urbanova, Renata ; Gabcova, Gabriela ; Kudelka, Milos ; Turcsányi, Peter ; Ryznerova, Pavlina ; Prochazka, Vit ; Kriegova, Eva</creatorcontrib><description>A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy controls. Neutrophils from CLL produced more reactive oxygen species (ROS) compared to controls in both resting and activated conditions. Lipopolysaccharide-induced production of IL-1β and TNF-a as well as reduced TLR2 expression in neutrophils from CLL than in neutrophils from controls suggesting their tolerant state. Finally, phenotypic alterations of neutrophils, particularly elevation of CD64 and CD54 markers, correlated with disease activity and treatment, and low percentage of neutrophils. Taken together, the alterations in percentage and functional characteristics of neutrophils reflect the clinical course of CLL. Our data provide first evidence that neutrophils in CLL are permanently primed and have functional defects.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.20031</identifier><identifier>PMID: 29156691</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2017-10, Vol.8 (49), p.84889-84901</ispartof><rights>Copyright: © 2017 Manukyan et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-2f638a819f6c7da810f17bb95090963fce654e48e229910e301b4eaf6dd15a0f3</citedby><cites>FETCH-LOGICAL-c356t-2f638a819f6c7da810f17bb95090963fce654e48e229910e301b4eaf6dd15a0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689581/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689581/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29156691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manukyan, Gayane</creatorcontrib><creatorcontrib>Papajik, Tomas</creatorcontrib><creatorcontrib>Gajdos, Petr</creatorcontrib><creatorcontrib>Mikulkova, Zuzana</creatorcontrib><creatorcontrib>Urbanova, Renata</creatorcontrib><creatorcontrib>Gabcova, Gabriela</creatorcontrib><creatorcontrib>Kudelka, Milos</creatorcontrib><creatorcontrib>Turcsányi, Peter</creatorcontrib><creatorcontrib>Ryznerova, Pavlina</creatorcontrib><creatorcontrib>Prochazka, Vit</creatorcontrib><creatorcontrib>Kriegova, Eva</creatorcontrib><title>Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy controls. Neutrophils from CLL produced more reactive oxygen species (ROS) compared to controls in both resting and activated conditions. Lipopolysaccharide-induced production of IL-1β and TNF-a as well as reduced TLR2 expression in neutrophils from CLL than in neutrophils from controls suggesting their tolerant state. Finally, phenotypic alterations of neutrophils, particularly elevation of CD64 and CD54 markers, correlated with disease activity and treatment, and low percentage of neutrophils. Taken together, the alterations in percentage and functional characteristics of neutrophils reflect the clinical course of CLL. Our data provide first evidence that neutrophils in CLL are permanently primed and have functional defects.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUctO3TAQtVARIMoHsKm87OaCHce-8aZShVpAQrApa2uuMyamiZ3azpXu3-PyKp3NHM3jzOMQcsrZGe-UaM5jsLFAesBy1jAm-B454rrVq0ZK8ekDPiQnOT-yarJdd40-IIeN5lIpzY8I3OJSUpwHP2bqA7VDisFbOu6meYh2V_5iXH7j5IFCQjpjmiBgKOOOgi1-CwV7CqGnA2yRuiXUYAww0h4d2pI_k30HY8aTV39M7n_--HVxtbq5u7y--H6zskKqsmqcEh10XDtl130FzPH1ZqMl00wr4Swq2WLbYdNozRkKxjctglN9zyUwJ47JtxfeedlM2Nu6YoLRzMlPkHYmgjf_Z4IfzEPcGqk6LTteCb6-EqT4Z8FczOSzxXGs58YlG67ryzqhhayl_KXUpphzQvc-hjPzrI75p455Vqf2fPm433vHmxbiCeEXkSI</recordid><startdate>20171017</startdate><enddate>20171017</enddate><creator>Manukyan, Gayane</creator><creator>Papajik, Tomas</creator><creator>Gajdos, Petr</creator><creator>Mikulkova, Zuzana</creator><creator>Urbanova, Renata</creator><creator>Gabcova, Gabriela</creator><creator>Kudelka, Milos</creator><creator>Turcsányi, Peter</creator><creator>Ryznerova, Pavlina</creator><creator>Prochazka, Vit</creator><creator>Kriegova, Eva</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171017</creationdate><title>Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects</title><author>Manukyan, Gayane ; Papajik, Tomas ; Gajdos, Petr ; Mikulkova, Zuzana ; Urbanova, Renata ; Gabcova, Gabriela ; Kudelka, Milos ; Turcsányi, Peter ; Ryznerova, Pavlina ; Prochazka, Vit ; Kriegova, Eva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-2f638a819f6c7da810f17bb95090963fce654e48e229910e301b4eaf6dd15a0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Manukyan, Gayane</creatorcontrib><creatorcontrib>Papajik, Tomas</creatorcontrib><creatorcontrib>Gajdos, Petr</creatorcontrib><creatorcontrib>Mikulkova, Zuzana</creatorcontrib><creatorcontrib>Urbanova, Renata</creatorcontrib><creatorcontrib>Gabcova, Gabriela</creatorcontrib><creatorcontrib>Kudelka, Milos</creatorcontrib><creatorcontrib>Turcsányi, Peter</creatorcontrib><creatorcontrib>Ryznerova, Pavlina</creatorcontrib><creatorcontrib>Prochazka, Vit</creatorcontrib><creatorcontrib>Kriegova, Eva</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manukyan, Gayane</au><au>Papajik, Tomas</au><au>Gajdos, Petr</au><au>Mikulkova, Zuzana</au><au>Urbanova, Renata</au><au>Gabcova, Gabriela</au><au>Kudelka, Milos</au><au>Turcsányi, Peter</au><au>Ryznerova, Pavlina</au><au>Prochazka, Vit</au><au>Kriegova, Eva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-10-17</date><risdate>2017</risdate><volume>8</volume><issue>49</issue><spage>84889</spage><epage>84901</epage><pages>84889-84901</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy controls. Neutrophils from CLL produced more reactive oxygen species (ROS) compared to controls in both resting and activated conditions. Lipopolysaccharide-induced production of IL-1β and TNF-a as well as reduced TLR2 expression in neutrophils from CLL than in neutrophils from controls suggesting their tolerant state. Finally, phenotypic alterations of neutrophils, particularly elevation of CD64 and CD54 markers, correlated with disease activity and treatment, and low percentage of neutrophils. Taken together, the alterations in percentage and functional characteristics of neutrophils reflect the clinical course of CLL. Our data provide first evidence that neutrophils in CLL are permanently primed and have functional defects.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>29156691</pmid><doi>10.18632/oncotarget.20031</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2017-10, Vol.8 (49), p.84889-84901
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5689581
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central; Free E- Journals
subjects Research Paper
title Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A31%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutrophils%20in%20chronic%20lymphocytic%20leukemia%20are%20permanently%20activated%20and%20have%20functional%20defects&rft.jtitle=Oncotarget&rft.au=Manukyan,%20Gayane&rft.date=2017-10-17&rft.volume=8&rft.issue=49&rft.spage=84889&rft.epage=84901&rft.pages=84889-84901&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.20031&rft_dat=%3Cproquest_pubme%3E1966983935%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1966983935&rft_id=info:pmid/29156691&rfr_iscdi=true